We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Risk of Contamination Reduced During Blood Culture Collection

By Labmedica staff writers
Posted on 28 Jul 2008
Print article
A newly developed kit provides a safer and easier process for blood culture collection that can help minimize contamination.

Blood cultures are critical in the early detection stage for sepsis--a severe, whole-body immune response to infection. Sepsis is a serious condition, which is caused by microbes or their toxins in blood or tissues. The new kit minimizes the risk of false-positive results from the lab, which can be expensive for both patients and hospitals.

The new WorkSafe blood culture kit includes BacT/Alert three-dimensional (3D) blood culture bottles, made of a multi-layer polycarbonate instead of glass, which decreases the risk of breakage and blood or body fluid exposures. This improves worker and patient safety by limiting the amount of potential exposure to biohazardous materials. The lightweight plastic bottles can be sent through pneumatic transportation tube systems without custom holders.

Launched by bioMérieux (Marcy l'Etoile, France), the kit is a key element of the company's WorkSafe campaign that equips hospital workers with one simple kit with all necessary components for safe and efficient blood culture-collection. The kit eliminates the need for nurses or phlebotomists to manually pull loose and disparate pieces together for blood culture collection. The kit also contains a disposal bag for all biohazardous materials.

bioMérieux provides diagnostic solutions (reagents, instruments, software), which determine the source of disease and contamination to improve patient health and ensure consumer safety. The products are used for diagnosing infectious diseases and providing high medical value results for cardiovascular emergencies, and cancer screening and monitoring. They are also used for detecting microorganisms in agri-food, pharmaceutic, and cosmetic products.


Related Links:
bioMérieux
Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
New
Troponin I Test
Quidel Triage Troponin I Test

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.